Open AccessIssue Information
Publication year - 2017
Publication title -
molecular oncology
Language(s) - Uncategorized
Resource type - Reports
SCImago Journal Rank - 2.332
H-Index - 88
eISSN - 1878-0261
pISSN - 1574-7891
DOI - 10.1002/1878-0261.12002
Subject(s) - sorafenib , citation , library science , information retrieval , computer science , medicine , hepatocellular carcinoma , cancer research
Dual inhibition of Akt and c‐Met as a second‐line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells, by P. Han et al . (pp. 320–334).